glp-1 weight loss for men How Semaglutide/GLP-1 Can Help You Achieve Long-Term 🚨 HORMONES & GLP‑1: More

Encourages Lasting Weight Balance Built to promote steady, consistent progress rather than temporary fixes

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), approved for diabetes and obesity, have shown promise in modulating reward-related brain pathways, suggesting potential benefits in the management of AUD

Coverage Baseline Previously unavailable under Medicare Part D Only 13 states cover them in Medicaid (KFF HMA survey) 19% of large employers cover GLP-1s for obesity, though 43% of employers with 5,000+ employees offer coverage (KFF 2025 survey) Current Expansion ~50% of CVS Caremark clients now provide coverage for weight loss Medicare GLP-1 Bridge program launches coverage for eligible Medicare Part D patients 7/1/26 This aligns with a recent survey from Business Group on Health that found 67% of the surveyed employers now cover GLP-1s for weight loss (though a reduction is expected for 2027)

Learn how injection timing affects side effects, what FDA guidelines say, and practical tips for consistent dosing to maximize your weight loss results with this once-weekly medication.

Prescription product

Froedtert & MCW Workforce Health is proud to introduce a new comprehensive weight-loss management program that is simple for employees to use and easy for your benefits team to manage.